Edition:
United States

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

80.00CHF
26 May 2017
Change (% chg)

-- (--)
Prev Close
CHF80.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
77,157
52-wk High
CHF95.35
52-wk Low
CHF61.20

Select another date:

Thu, Apr 27 2017

BRIEF-Basilea shareholders approve resolutions proposed by the board at the general meeting of shareholders

* Basilea shareholders approve all resolutions proposed by the board of directors at the ordinary general meeting of shareholders

BRIEF-Basilea Pharmaceutica: agreement with FDA regarding ceftobiprole

* Basilea announces agreement with FDA on special protocol assessments for antibiotic ceftobiprole phase 3 clinical studies in bloodstream and skin infections

BRIEF-Basilea Pharmaceutica FY 2016 net loss narrows to CHF 51.3 million

* In 2017, Basilea will further advance clinical development of its oncology drug candidates and expects to complete dose-escalation in bal101553's phase 1/2a studies and bal 3833's phase 1 study

Select another date:

More From Around the Web